U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111325) titled 'Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus' on July 31.
Brief Summary: Evaluate the safety and preliminary efficacy of human induced pluripotent stem cell-derived extracellular vesicle (iEV) injection in the treatment of lateral epicondylitis of the humerus.
Study Start Date: July 01, 2023
Study Type: INTERVENTIONAL
Condition:
Lateral Epicondylitis
Intervention:
BIOLOGICAL: iEV
induced pluripotent stem cell-derived extracellular vesicles
BIOLOGICAL: PRP
PRP injection
OTHER: immobilization
immobilization
Recruitment Status: RECRUITING
Sponsor: Shanghai 6th People's Hospi...